Profil
Luciano D'Adamio is the founder and chairman of RemeGenix, Inc. which is founded in 2006.
He is also the founder of Kappa Lifescience Ltd.
and Sienagen S R L.
Currently, he holds the position of Professor-Immunology & Microbiology at Albert Einstein College of Medicine, Inc.
Aktive Positionen von Luciano D'Adamio
| Unternehmen | Position | Beginn |
|---|---|---|
| REMEGENIX, INC. | Gründer | 28.04.2006 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Luciano D'Adamio
| Unternehmen | Position | Ende |
|---|---|---|
| Sienagen S R L | Gründer | - |
| Kappa Lifescience Ltd. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
RemeGenix, Inc.
 RemeGenix, Inc. Pharmaceuticals: MajorHealth Technology RemeGenix, Inc. is a biotechnology company, which engages in the development of drug MoBA which is used for treatment of Alzheimer's disease. Its product pipe lines include NoMAD, which is one of the preferred animal models used in the development of a variety of Alzheimer's and ementia drug development efforts and MoBA. The company was founded by Luciano D'Adamio and J. Kelly Ganjei on April 28, 2006 and is headquartered in Bethesda, MD. | Health Technology |
| Kappa Lifescience Ltd. | |
| Sienagen S R L |
